These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9873761)

  • 1. New methods for inactivation of lipid-enveloped and non-enveloped viruses.
    Miekka SI; Busby TF; Reid B; Pollock R; Ralston A; Drohan WN
    Haemophilia; 1998 Jul; 4(4):402-8. PubMed ID: 9873761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration.
    Troccoli NM; McIver J; Losikoff A; Poiley J
    Biologicals; 1998 Dec; 26(4):321-9. PubMed ID: 10403036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effectiveness of the SurePure Turbulator ultraviolet-C irradiation equipment on inactivation of different enveloped and non-enveloped viruses inoculated in commercially collected liquid animal plasma.
    Blázquez E; Rodríguez C; Ródenas J; Navarro N; Riquelme C; Rosell R; Campbell J; Crenshaw J; Segalés J; Pujols J; Polo J
    PLoS One; 2019; 14(2):e0212332. PubMed ID: 30789926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma irradiation of intravenous immunoglobulin.
    Drohan WN; Miekka SI; Griko YV; Forng RY; Stafford RE; Hill CR; Mann DM; Burgess WH
    Dev Biol (Basel); 2004; 118():133-8. PubMed ID: 15645683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
    Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
    Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid.
    Radomski KU; Lattner G; Schmidt T; Römisch J
    BioDrugs; 2017 Apr; 31(2):125-134. PubMed ID: 28236170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine.
    Gugerell A; Sorgenfrey D; Laggner M; Raimann J; Peterbauer A; Bormann D; Suessner S; Gabriel C; Moser B; Ostler T; Mildner M; Ankersmit HJ
    Blood Transfus; 2020 Jan; 18(1):30-39. PubMed ID: 30865581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity.
    Poelsler G; Berting A; Kindermann J; Spruth M; Hämmerle T; Teschner W; Schwarz HP; Kreil TR
    Vox Sang; 2008 Apr; 94(3):184-192. PubMed ID: 18167162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of lipid-enveloped and non-lipid-enveloped model viruses in normal human plasma by crosslinked starch-iodine.
    Highsmith FA; Xue H; Caple M; Walthall B; Drohan WN; Shanbrom E
    Transfusion; 1994 Apr; 34(4):322-7. PubMed ID: 8178330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography.
    Lebing W; Remington KM; Schreiner C; Paul HI
    Vox Sang; 2003 Apr; 84(3):193-201. PubMed ID: 12670368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19.
    Caillet-Fauquet P; Di Giambattista M; Draps ML; Sandras F; Branckaert T; de Launoit Y; Laub R
    J Virol Methods; 2004 Jun; 118(2):131-9. PubMed ID: 15081608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of enveloped and non-enveloped viruses in the process of chemical treatment and gamma irradiation of bovine-derived grafting materials.
    Lee KI; Lee JS; Jung HH; Lee HY; Moon SH; Kang KT; Shim YB; Jang JW
    Xenotransplantation; 2012; 19(6):365-9. PubMed ID: 23198732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikungunya virus and the safety of plasma products.
    Leydold SM; Farcet MR; Kindermann J; Modrof J; Pölsler G; Berting A; Howard MK; Barrett PN; Kreil TR
    Transfusion; 2012 Oct; 52(10):2122-30. PubMed ID: 22339168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of lipid enveloped viruses by octanoic Acid treatment of immunoglobulin solution.
    Dichtelmüller H; Rudnick D; Kloft M
    Biologicals; 2002 Jun; 30(2):135-42. PubMed ID: 12127315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates.
    Hart HF; Hart WG; Crossley J; Perrie AM; Wood DJ; John A; McOmish F
    Vox Sang; 1994; 67(4):345-50. PubMed ID: 7701804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two different methods for inactivation of viruses in serum.
    Preuss T; Kamstrup S; Kyvsgaard NC; Nansen P; Miller A; Lei JC
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):504-8. PubMed ID: 9302195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process.
    Bos OJ; Sunyé DG; Nieuweboer CE; van Engelenburg FA; Schuitemaker H; Over J
    Biologicals; 1998 Dec; 26(4):267-76. PubMed ID: 10403030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus reduction in the preparation of intravenous immune globulin: in vitro experiments.
    Chandra S; Cavanaugh JE; Lin CM; Pierre-Jerome C; Yerram N; Weeks R; Flanigan E; Feldman F
    Transfusion; 1999 Mar; 39(3):249-57. PubMed ID: 10204586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of inactivation of viral contaminants in hyperimmune horse plasma against botulinum toxin by low pH alone and combined with pepsin digestion.
    Torgeman A; Mador N; Dorozko M; Lifshitz A; Eschar N; White MD; Wolf DG; Epstein E
    Biologicals; 2017 Jul; 48():24-27. PubMed ID: 28633975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.